(Q33936343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

J Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

M Roh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

I Doubinskaia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

I-E A Eltoum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S A Abdulkadir

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

20 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

322-332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

Integrative genomic profiling of human prostate cancer

5 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-kappaB activation and invasive prostate carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Combinatorial patterns of somatic gene mutations in cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

The biology and clinical relevance of the PTEN tumor suppressor pathway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Expression of PTEN in malignant and non-malignant human prostate tissues: comparison with p27 protein expression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Impaired prostate tumorigenesis in Egr1-deficient mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Evidence of independent origin of multiple tumors from patients with prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

p53 is mutated in a subset of advanced-stage prostate cancers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Evaluation of biomarkers in breast and prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

p53 in prostate cancer: frequent expressed transition mutations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

A genetic model for colorectal tumorigenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Epigenetic and genetic alternation of PTEN in cervical neoplasm.

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Myc-driven murine prostate cancer shares molecular features with human prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

p53 mutations occur in clinical, but not latent, human prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Is PTEN loss associated with clinical outcome measures in human prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP).

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

p53 gene alterations in human prostate carcinoma

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3179816

Analysis of PTEN and the 10q23 region in primary prostate carcinomas

29 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

p53 oncogene mutations in human prostate cancer specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.236

Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21685943

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An uncertain role for p53 gene alterations in human prostate cancers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21685943

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21685943

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2011.236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21685943%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

PubMed publication ID

21685943

1 reference